Home LiteratureArticle Details
PMID: 22366781 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Cancer metastasis reviews ·Vol. 31 ·No. 1-2 ·2012-06-00 ·Pages 295-321

Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R

Abstract

Almost all human cancers display dysregulated expression and/or function of one or more receptor tyrosine kinases (RTKs). The strong causative association between altered RTK function and cancer progression has been translated into novel therapeutic strategies that target these cell surface receptors in cancer. Yet, the full spectrum of RTKs that may alter the oncogenic process is not completely understood. Accumulating evidence suggests that a unique set of RTKs known as the discoidin domain receptors (DDRs) play a key role in cancer progression by regulating the interactions of tumor cells with their surrounding collagen matrix. The DDRs are the only RTKs that specifically bind to and are activated by collagen. DDRs control cell and tissue homeostasis by acting as collagen sensors, transducing signals that regulate cell polarity, tissue morphogenesis, and cell differentiation. In cancer, DDRs are hijacked by tumor cells to disrupt normal cell-matrix communication and initiate pro-migratory and pro-invasive programs. Importantly, several cancer types exhibit DDR mutations, which are thought to alter receptor function and contribute to cancer progression. Other evidence suggests that the actions of DDRs in cancer are complex, either promoting or suppressing tumor cell behavior in a DDR type/isoform specific- and context-dependent manner. Thus, there is still a considerable gap in our knowledge of DDR actions in cancer tissues. This review summarizes and discusses the current knowledge on DDR expression and function in cancer. It is hoped that this effort will encourage more research into these poorly understood but unique RTKs, which have the potential of becoming novel therapeutic targets in cancer.

MeSH Terms
Animals Collagen/metabolism Discoidin Domain Receptors Disease Progression Enzyme Activation Gene Expression Regulation, Neoplastic Humans Molecular Targeted Therapy Mutation Neoplasms/drug therapy,enzymology,genetics Protein Binding Protein Processing, Post-Translational Protein Structure, Tertiary Receptor Protein-Tyrosine Kinases/antagonists & inhibitors,chemistry,genetics,metabolism Receptors, Mitogen/antagonists & inhibitors,chemistry,genetics,metabolism Signal Transduction
Chemicals
Receptors, Mitogen Collagen Discoidin Domain Receptors Receptor Protein-Tyrosine Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Valiathan Rajeshwari R
Department of Pathology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Marco Marta
Leitinger Birgit
Kleer Celina G
Fridman Rafael
References (187)
187 references, click to expand
  1. Multiple tyrosine protein kinases in rat hippocampal neurons: isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain.
    Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1819-23 PMID: 8127887
  2. Somatic mutations of the protein kinase gene family in human lung cancer.
    Cancer Res. 2005 Sep 1;65(17):7591-5 PMID: 16140923
  3. Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production.
    Eur Respir J. 2011 Jun;37(6):1482-93 PMID: 20884741
  4. Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation.
    Cancer Res. 2006 Aug 15;66(16):8123-30 PMID: 16912190
  5. Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor.
    J Biol Chem. 2004 Jul 23;279(30):31462-70 PMID: 15136580
  6. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma.
    Blood. 2005 May 15;105(10):4051-9 PMID: 15677564
  7. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice.
    Circ Res. 2008 May 23;102(10):1202-11 PMID: 18451340
  8. The discoidin domain receptor 1 gene has a functional A2RE sequence.
    J Neurochem. 2012 Feb;120(3):408-18 PMID: 22077590
  9. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.
    Oncogene. 2005 Mar 31;24(14):2375-85 PMID: 15674322
  10. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
    Oncol Rep. 2011 Oct;26(4):971-8 PMID: 21701781
  11. Functional analysis of discoidin domain receptor 2 in synovial fibroblasts in rheumatoid arthritis.
    J Autoimmun. 2002 Nov;19(3):161-8 PMID: 12419287
  12. Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons.
    Genes Dev. 2000 Sep 1;14(17):2216-28 PMID: 10970885
  13. Structure and expression of the Tyro 10 receptor tyrosine kinase.
    Oncogene. 1994 Mar;9(3):877-83 PMID: 8108131
  14. The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction.
    Protein Sci. 1998 Jul;7(7):1626-31 PMID: 9684896
  15. Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion.
    Int J Cancer. 2003 Jan 20;103(3):344-51 PMID: 12471617
  16. Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1.
    J Neurooncol. 2007 Mar;82(1):29-40 PMID: 17001518
  17. Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis.
    Circ Res. 2009 Nov 20;105(11):1141-8 PMID: 19834008
  18. Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices.
    FASEB J. 2001 Dec;15(14):2724-6 PMID: 11606478
  19. Structure, expression and chromosomal mapping of TKT from man and mouse: a new subclass of receptor tyrosine kinases with a factor VIII-like domain.
    Oncogene. 1993 Dec;8(12):3433-40 PMID: 8247548
  20. Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2.
    J Mol Biol. 2010 Jan 22;395(3):533-43 PMID: 19900459
  21. Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells.
    Clin Exp Metastasis. 2011 Jun;28(5):463-77 PMID: 21461859
  22. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
    Mol Cancer. 2010 Aug 27;9:227 PMID: 20799954
  23. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells.
    Eur J Cell Biol. 2010 Nov;89(11):843-52 PMID: 20709424
  24. KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling.
    Biochim Biophys Acta. 2008 Mar;1783(3):383-93 PMID: 18190796
  25. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.
    Cardiovasc Pathol. 2011 Mar-Apr;20(2):71-6 PMID: 20093046
  26. Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen.
    J Biol Chem. 2005 Dec 2;280(48):40187-94 PMID: 16186104
  27. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.
    Cell. 2007 Dec 14;131(6):1190-203 PMID: 18083107
  28. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
    Cancer Discov. 2011 Jun;1(1):78-89 PMID: 22328973
  29. Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells.
    J Cell Sci. 2001 Jun;114(Pt 11):2043-53 PMID: 11493640
  30. The discovery of receptor tyrosine kinases: targets for cancer therapy.
    Nat Rev Cancer. 2004 May;4(5):361-70 PMID: 15122207
  31. Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2.
    J Biol Chem. 2003 May 9;278(19):16761-9 PMID: 12611880
  32. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets.
    Blood. 2007 Dec 1;110(12):4055-63 PMID: 17720881
  33. Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions.
    Biochem Soc Trans. 2008 Apr;36(Pt 2):241-50 PMID: 18363567
  34. An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation.
    J Bone Miner Res. 2011 Mar;26(3):604-17 PMID: 20734453
  35. NEP: a novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia.
    Oncogene. 1993 Oct;8(10):2731-9 PMID: 8397369
  36. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
    J Cell Biol. 2006 Nov 20;175(4):563-9 PMID: 17101694
  37. DDR1/E-cadherin complex regulates the activation of DDR1 and cell spreading.
    Am J Physiol Cell Physiol. 2009 Aug;297(2):C419-29 PMID: 19474292
  38. Overexpression of protein tyrosine kinases in human esophageal cancer.
    Pathobiology. 1997;65(4):195-203 PMID: 9396043
  39. Implication of discoidin domain receptor 1 in T cell migration in three-dimensional collagen.
    Mol Immunol. 2010 May;47(9):1866-9 PMID: 20353877
  40. Initial dynamics of cell spreading are governed by dissipation in the actin cortex.
    Biophys J. 2011 Aug 3;101(3):611-21 PMID: 21806929
  41. Discoidin domain receptor 2 (DDR2) is required for maintenance of spermatogenesis in male mice.
    Mol Reprod Dev. 2010 Jan;77(1):29-37 PMID: 19681157
  42. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
    Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53 PMID: 18938156
  43. Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy.
    J Mol Biol. 2009 Jan 16;385(2):432-45 PMID: 19007791
  44. Cell signaling by receptor tyrosine kinases.
    Cell. 2010 Jun 25;141(7):1117-34 PMID: 20602996
  45. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors.
    Mol Cell. 1997 Dec;1(1):25-34 PMID: 9659900
  46. Ligand-induced shedding of discoidin domain receptor 1.
    FEBS Lett. 2002 Mar 13;514(2-3):175-80 PMID: 11943146
  47. Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma.
    Head Neck. 2008 Apr;30(4):427-36 PMID: 18023033
  48. Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases.
    Pediatr Neurosurg. 1996 Aug;25(2):64-71; discussion 71-2 PMID: 9075249
  49. DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation.
    J Cell Physiol. 2010 Aug;224(2):387-97 PMID: 20432435
  50. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
    Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):520-8 PMID: 15701836
  51. Collagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1.
    Matrix Biol. 2011 Jan;30(1):16-26 PMID: 21044884
  52. Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours.
    Oncogene. 1995 Feb 2;10(3):569-75 PMID: 7845682
  53. Discoidin domain receptor 2 impairs insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation and glucose uptake in 3T3-L1 adipocytes.
    Horm Metab Res. 2007 Aug;39(8):575-81 PMID: 17712722
  54. Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart.
    Dev Biol. 2010 Feb 15;338(2):251-61 PMID: 20025864
  55. Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1.
    Lab Invest. 2008 Jan;88(1):27-37 PMID: 18026164
  56. The relative roles of collagen adhesive receptor DDR2 activation and matrix stiffness on the downregulation of focal adhesion kinase in vascular smooth muscle cells.
    Biomaterials. 2009 Dec;30(35):6687-94 PMID: 19762078
  57. Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function.
    Physiol Genomics. 2009 Oct 7;39(2):120-9 PMID: 19671659
  58. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.
    EMBO J. 2003 Mar 17;22(6):1289-301 PMID: 12628922
  59. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
    Blood. 2008 May 1;111(9):4797-808 PMID: 18270328
  60. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
    Oncol Rep. 2010 Aug;24(2):311-9 PMID: 20596615
  61. A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration.
    Mol Biol Cell. 2006 Jun;17(6):2839-52 PMID: 16611743
  62. RNA interference for discoidin domain receptor 2 attenuates neointimal formation in balloon injured rat carotid artery.
    Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1447-53 PMID: 18497308
  63. Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen.
    J Biol Chem. 2008 Mar 14;283(11):6861-8 PMID: 18201965
  64. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation.
    J Bone Miner Res. 2010 Nov;25(11):2489-503 PMID: 20564243
  65. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.
    PLoS One. 2011 Jan 06;6(1):e15640 PMID: 21253578
  66. A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain.
    Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10891 PMID: 8248187
  67. Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver.
    Am J Pathol. 2011 Mar;178(3):1134-44 PMID: 21356365
  68. Structural basis of the collagen-binding mode of discoidin domain receptor 2.
    EMBO J. 2007 Sep 19;26(18):4168-76 PMID: 17703188
  69. Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro.
    J Mol Neurosci. 2009 May;38(1):2-11 PMID: 18836851
  70. Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients.
    Hum Mol Genet. 2010 Jun 1;19(11):2239-50 PMID: 20223752
  71. Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1.
    J Proteomics. 2012 Jun 27;75(12):3465-77 PMID: 22057045
  72. Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding.
    J Biol Chem. 2001 Dec 7;276(49):45952-8 PMID: 11598108
  73. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.
    Br J Cancer. 2007 Mar 12;96(5):808-14 PMID: 17299390
  74. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
    BMC Cancer. 2007 Mar 27;7:55 PMID: 17389037
  75. The discoidin domain receptor tyrosine kinases are activated by collagen.
    Mol Cell. 1997 Dec;1(1):13-23 PMID: 9659899
  76. Somatic mutations affect key pathways in lung adenocarcinoma.
    Nature. 2008 Oct 23;455(7216):1069-75 PMID: 18948947
  77. Discoidin proteins of Dictyostelium are necessary for normal cytoskeletal organization and cellular morphology during aggregation.
    Differentiation. 1992 Nov;51(3):149-61 PMID: 1334012
  78. Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy.
    Nat Biotechnol. 2009 Jan;27(1):77-83 PMID: 19098899
  79. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis.
    Arthritis Rheum. 2007 Aug;56(8):2663-73 PMID: 17665456
  80. Switching in discoid domain receptor expressions in SLUG-induced epithelial-mesenchymal transition.
    Cancer. 2008 Nov 15;113(10):2823-31 PMID: 18853422
  81. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
    J Biol Chem. 2011 Apr 15;286(15):12912-23 PMID: 21335558
  82. Suppression of hepatic stellate cell activation by microRNA-29b.
    Biochem Biophys Res Commun. 2011 Aug 19;412(1):74-9 PMID: 21798245
  83. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis.
    Am J Respir Crit Care Med. 2006 Aug 15;174(4):420-7 PMID: 16690978
  84. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
    J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52 PMID: 20521089
  85. Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis.
    Gut. 2012 Oct;61(10):1465-72 PMID: 22071959
  86. Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications.
    Am J Hum Genet. 2009 Jan;84(1):80-4 PMID: 19110212
  87. Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease.
    J Am Soc Nephrol. 2006 Dec;17(12):3374-81 PMID: 17093065
  88. High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
    Blood. 2008 May 1;111(9):4788-96 PMID: 18252861
  89. Navigating ECM barriers at the invasive front: the cancer cell-stroma interface.
    Annu Rev Cell Dev Biol. 2009;25:567-95 PMID: 19575644
  90. DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells.
    J Clin Invest. 2001 Nov;108(9):1369-78 PMID: 11696582
  91. Binding of discoidin domain receptor 2 to collagen I: an atomic force microscopy investigation.
    Biochemistry. 2002 Sep 17;41(37):11091-8 PMID: 12220173
  92. DDR1 signaling is essential to sustain Stat5 function during lactogenesis.
    J Cell Biochem. 2006 Jan 1;97(1):109-21 PMID: 16167341
  93. CD167 acts as a novel costimulatory receptor in T-cell activation.
    J Immunother. 2009 Oct;32(8):773-84 PMID: 19752756
  94. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.
    J Neurooncol. 2006 Feb;76(3):239-48 PMID: 16234985
  95. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.
    Nat Chem Biol. 2010 Apr;6(4):291-9 PMID: 20190765
  96. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
    Clin Cancer Res. 2005 Oct 15;11(20):7209-19 PMID: 16243790
  97. Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors.
    Cell Mol Life Sci. 2011 Nov;68(22):3757-70 PMID: 21499918
  98. Discoidin domain receptor 1 controls growth and adhesion of mesangial cells.
    J Am Soc Nephrol. 2002 Nov;13(11):2648-56 PMID: 12397034
  99. DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria.
    Kidney Int. 2004 Jul;66(1):102-11 PMID: 15200417
  100. LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation.
    J Pharmacol Exp Ther. 2012 Mar;340(3):510-9 PMID: 22128347
  101. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism.
    EMBO Rep. 2001 May;2(5):446-52 PMID: 11375938
  102. Collagen-induced expression of collagenase-3 by primary chondrocytes is mediated by integrin α1 and discoidin domain receptor 2: a protein kinase C-dependent pathway.
    Rheumatology (Oxford). 2011 Mar;50(3):463-72 PMID: 21075784
  103. Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins.
    Proteomics. 2009 Nov;9(21):4944-61 PMID: 19743411
  104. Structural similarities and functional diversity of eukaryotic discoidin-like domains.
    Biochim Biophys Acta. 2007 Sep;1774(9):1069-78 PMID: 17702679
  105. Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling.
    Fibrogenesis Tissue Repair. 2011 Feb 02;4(1):5 PMID: 21288331
  106. Interaction of discoidin domain receptor 1 with collagen type 1.
    J Mol Biol. 2007 Mar 23;367(2):443-55 PMID: 17275838
  107. Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity.
    J Cell Physiol. 2009 Jan;218(1):146-56 PMID: 18780290
  108. Components of cell-matrix adhesions.
    J Cell Sci. 2001 Oct;114(Pt 20):3577-9 PMID: 11707509
  109. Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1.
    J Mol Biol. 2006 Sep 1;361(5):864-76 PMID: 16884738
  110. Targeting cancer with small molecule kinase inhibitors.
    Nat Rev Cancer. 2009 Jan;9(1):28-39 PMID: 19104514
  111. The discoidin domain receptor DDR2 is a receptor for type X collagen.
    Matrix Biol. 2006 Aug;25(6):355-64 PMID: 16806867
  112. Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines.
    Oncogene. 1996 Apr 4;12(7):1469-77 PMID: 8622863
  113. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair.
    J Clin Invest. 2001 Mar;107(6):727-35 PMID: 11254672
  114. Functional analysis of discoidin domain receptor 1: effect of adhesion on DDR1 phosphorylation.
    FASEB J. 2002 Feb;16(2):234-6 PMID: 11772944
  115. The collagen receptor DDR2 is expressed during early cardiac development.
    Anat Rec (Hoboken). 2010 May;293(5):762-9 PMID: 19479965
  116. Transmembrane collagen receptors.
    Annu Rev Cell Dev Biol. 2011;27:265-90 PMID: 21568710
  117. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development.
    Mol Cell Biol. 2001 Apr;21(8):2906-17 PMID: 11283268
  118. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
    Oncol Rep. 2007 Oct;18(4):917-26 PMID: 17786355
  119. Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen.
    J Biol Chem. 2002 May 24;277(21):19206-12 PMID: 11884411
  120. Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines.
    FASEB J. 2001 May;15(7):1321-3 PMID: 11344127
  121. Molecular markers of endometrial carcinoma detected in uterine aspirates.
    Int J Cancer. 2011 Nov 15;129(10):2435-44 PMID: 21207424
  122. Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration.
    Biochem Biophys Res Commun. 2008 Oct 3;374(4):662-7 PMID: 18664364
  123. A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells.
    Leukemia. 2010 Jan;24(1):44-50 PMID: 19890374
  124. The genomic structure of discoidin receptor tyrosine kinase.
    Genome Res. 1996 Jul;6(7):620-7 PMID: 8796349
  125. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting.
    J Pathol. 2010 Jul;221(3):300-7 PMID: 20527023
  126. Pathway analysis of primary central nervous system lymphoma.
    Blood. 2008 Mar 15;111(6):3200-10 PMID: 18184868
  127. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.
    Clin Cancer Res. 2004 Jul 1;10(13):4427-36 PMID: 15240533
  128. Epithelial-mesenchymal transitions in development and disease.
    Cell. 2009 Nov 25;139(5):871-90 PMID: 19945376
  129. Analysis of altered gene expression specific to embryotoxic chemical treatment during embryonic stem cell differentiation into myocardiac and neural cells.
    J Toxicol Sci. 2011 Oct;36(5):569-85 PMID: 22008533
  130. Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues.
    J Biol Chem. 1993 Nov 15;268(32):24290-5 PMID: 8226977
  131. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1.
    Exp Cell Res. 2006 Dec 10;312(20):4011-8 PMID: 17027969
  132. Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1.
    FEBS Lett. 2006 Jan 9;580(1):15-22 PMID: 16337946
  133. Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression.
    Circ Res. 2002 Jun 14;90(11):1147-9 PMID: 12065315
  134. Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.
    Am J Pathol. 2011 Jul;179(1):83-91 PMID: 21640971
  135. A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse.
    Mol Endocrinol. 2008 Aug;22(8):1866-80 PMID: 18483174
  136. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha.
    Fibrogenesis Tissue Repair. 2010 Jan 05;3(1):2 PMID: 20051102
  137. Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain.
    Oncogene. 1994 Jan;9(1):211-9 PMID: 8302582
  138. Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel.
    J Cell Physiol. 2005 Apr;203(1):295-304 PMID: 15468059
  139. Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors.
    Gastroenterology. 2006 Nov;131(5):1597-610 PMID: 17064702
  140. Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Jun;151(1):59-64 PMID: 17690741
  141. DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.
    Mol Biol Cell. 2011 Apr;22(7):940-53 PMID: 21289093
  142. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6.
    Nat Cell Biol. 2011 Jan;13(1):49-58 PMID: 21170030
  143. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.
    Head Neck. 2002 Sep;24(9):874-87 PMID: 12211052
  144. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors.
    Nat Biotechnol. 2007 Sep;25(9):1035-44 PMID: 17721511
  145. Discoidin domain receptor 1 is activated independently of beta(1) integrin.
    J Biol Chem. 2000 Feb 25;275(8):5779-84 PMID: 10681566
  146. Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages.
    Am J Pathol. 2011 Dec;179(6):2894-904 PMID: 22019896
  147. DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation.
    J Biol Chem. 2011 May 20;286(20):17672-81 PMID: 21398698
  148. Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library.
    Biol Pharm Bull. 2009 Jan;32(1):136-41 PMID: 19122296
  149. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer.
    Oncogene. 1995 Feb 2;10(3):609-18 PMID: 7845687
  150. The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells.
    PLoS One. 2011 Jan 24;6(1):e16394 PMID: 21283680
  151. Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-alpha and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2.
    Clin Sci (Lond). 2009 Apr;116(7):575-83 PMID: 18821853
  152. Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1.
    J Cell Biol. 2008 Mar 24;180(6):1277-89 PMID: 18362184
  153. Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis.
    Am J Pathol. 2004 May;164(5):1575-85 PMID: 15111304
  154. Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2.
    J Biol Chem. 2002 Feb 1;277(5):3606-13 PMID: 11723120
  155. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition.
    Matrix Biol. 2011 May;30(4):243-7 PMID: 21477649
  156. Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.
    Cancer Sci. 2008 Jan;99(1):39-45 PMID: 17970783
  157. Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data.
    J Biomed Inform. 2010 Jun;43(3):376-84 PMID: 20434586
  158. Soluble adhesion molecules in human cancers: sources and fates.
    Eur J Cell Biol. 2010 Jun;89(6):415-27 PMID: 20227133
  159. Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1.
    Circ Res. 2010 Jun 11;106(11):1775-83 PMID: 20448217
  160. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice.
    J Biol Chem. 2005 Jan 7;280(1):548-55 PMID: 15509586
  161. Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer.
    Int J Mol Sci. 2011 Jan 31;12(2):971-82 PMID: 21541037
  162. The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA.
    J Cell Sci. 2009 May 15;122(Pt 10):1637-46 PMID: 19401332
  163. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
    Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54 PMID: 20713713
  164. Collagen I regulates the self-renewal of mouse embryonic stem cells through α2β1 integrin- and DDR1-dependent Bmi-1.
    J Cell Physiol. 2011 Dec;226(12):3422-32 PMID: 21344393
  165. Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis.
    Mol Cell Biochem. 2009 Oct;330(1-2):141-52 PMID: 19415460
  166. Identification of expressed genes characterizing long-term survival in malignant glioma patients.
    Oncogene. 2006 Sep 28;25(44):5994-6002 PMID: 16652150
  167. Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: involvement of Src tyrosine kinase.
    J Cell Biochem. 2006 Jun 1;98(3):672-84 PMID: 16440311
  168. Crystallographic insight into collagen recognition by discoidin domain receptor 2.
    Structure. 2009 Dec 9;17(12):1573-1581 PMID: 20004161
  169. Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization.
    Am J Pathol. 2009 Dec;175(6):2686-96 PMID: 19893047
  170. Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib.
    Leuk Lymphoma. 2008 Apr;49(4):615-9 PMID: 18398720
  171. Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1.
    J Biol Chem. 2008 May 2;283(18):12026-33 PMID: 18065762
  172. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
    Matrix Biol. 2010 Jun;29(5):346-56 PMID: 20307660
  173. Cancer driver mutations in protein kinase genes.
    Cancer Lett. 2009 Aug 28;281(2):117-27 PMID: 19081671
  174. A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1.
    J Biol Chem. 2006 Aug 11;281(32):22744-51 PMID: 16774916
  175. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.
    Clin Cancer Res. 2012 Feb 15;18(4):969-80 PMID: 22223527
  176. Receptor protein tyrosine kinase DDR is up-regulated by p53 protein.
    FEBS Lett. 1996 Dec 2;398(2-3):165-9 PMID: 8977099
  177. Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors.
    Neurosurgery. 2000 Dec;47(6):1400-9 PMID: 11126911
  178. Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2.
    J Mol Biol. 2009 Jan 23;385(3):902-11 PMID: 18996394
  179. Deletion of discoidin domain receptor 2 does not affect smooth muscle cell adhesion, migration, or proliferation in response to type I collagen.
    Cardiovasc Pathol. 2012 May-Jun;21(3):214-8 PMID: 21865059
  180. Mesenchymal Stem Cells Sense Three Dimensional Type I Collagen through Discoidin Domain Receptor 1.
    Open Stem Cell J. 2009;1:40-53 PMID: 20589230
  181. Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line.
    Cell Growth Differ. 1994 Nov;5(11):1173-83 PMID: 7848919
  182. Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway.
    J Cell Biochem. 2011 Dec;112(12):3666-74 PMID: 21815193
  183. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.
    Development. 2007 Nov;134(21):3929-39 PMID: 17898001
  184. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Haematologica. 2006 May;91(5):596-604 PMID: 16670065
  185. Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase.
    Oncol Rep. 2007 Dec;18(6):1435-41 PMID: 17982627
  186. Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation.
    J Biol Chem. 2005 Nov 25;280(47):39058-66 PMID: 16186108
  187. The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.
    J Mol Biol. 2004 Dec 3;344(4):993-1003 PMID: 15544808
Article Info
Journal
Cancer metastasis reviews
Abbr.
Cancer Metastasis Rev
ISSN
1573-7233
Published
2012-06-00
Pages
295-321
Language
English
Region
Netherlands
NLM ID
8605731
PMCID
PMC3351584
Subset
IM
Grants
NCI NIH HHS · R01 CA125577 · United States
Medical Research Council · G0701121 · United Kingdom
NCI NIH HHS · CA-107469 · United States
NCI NIH HHS · R01 CA061986 · United States
NCI NIH HHS · R01 CA061986-16 · United States
NCI NIH HHS · R01 CA-125577 · United States
NCI NIH HHS · R01 CA-61986 · United States
NCI NIH HHS · R01 CA107469 · United States
Biotechnology and Biological Sciences Research Council · BB/IO11226/1 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com